MagNA Pure 96 系统用于临床样本中巨细胞病毒核酸扩增检测的性能。
Performance of the MagNA Pure 96 system for cytomegalovirus nucleic acid amplification testing in clinical samples.
机构信息
Labor Berlin-Charité Vivantes GmbH, Virology, Berlin, Germany.
出版信息
J Clin Microbiol. 2013 May;51(5):1600-1. doi: 10.1128/JCM.03289-12. Epub 2013 Mar 6.
Abstract
This report shows the performance of MagNA Pure 96 automated nucleic acid extraction for the quantitative detection of cytomegalovirus DNA in clinical samples by real-time PCR. The obtained results demonstrate that this workflow is characterized by high sensitivity and linearity and ensures reliable, reproducible clinical diagnostics.
摘要
本报告展示了 MagNA Pure 96 自动化核酸提取系统在实时 PCR 定量检测临床样本中巨细胞病毒 DNA 方面的性能。所得结果表明，该工作流程具有高灵敏度和线性度，可确保可靠、可重复的临床诊断。
相似文献
1
Performance of the MagNA Pure 96 system for cytomegalovirus nucleic acid amplification testing in clinical samples.MagNA Pure 96 系统用于临床样本中巨细胞病毒核酸扩增检测的性能。
J Clin Microbiol. 2013 May;51(5):1600-1. doi: 10.1128/JCM.03289-12. Epub 2013 Mar 6.
2
Comparison of 2 highly automated nucleic acid extraction systems for quantitation of human cytomegalovirus in whole blood.比较两种高度自动化的核酸提取系统在全血中定量检测人巨细胞病毒的效果。
Diagn Microbiol Infect Dis. 2011 Feb;69(2):161-6. doi: 10.1016/j.diagmicrobio.2010.08.011.
3
A new highly automated extraction system for quantitative real-time PCRs from whole blood samples: routine monitoring of opportunistic infections in immunosuppressed patients.一种新的全自动从全血样本中提取定量实时 PCR 的系统：免疫抑制患者机会性感染的常规监测。
J Clin Virol. 2012 Apr;53(4):314-9. doi: 10.1016/j.jcv.2012.01.002. Epub 2012 Jan 30.
4
Comparison of two nucleic acid extraction and testing systems for HCMV-DNA detection and quantitation on whole blood specimens from transplant patients.比较两种核酸提取和检测系统，用于检测和定量移植患者全血标本中的 HCMV-DNA。
J Virol Methods. 2013 Nov;193(2):579-82. doi: 10.1016/j.jviromet.2013.07.042. Epub 2013 Aug 4.
5
Automated Nucleic Acid Extraction Systems for Detecting Cytomegalovirus and Epstein-Barr Virus Using Real-Time PCR: A Comparison Study Between the QIAsymphony RGQ and QIAcube Systems.使用实时荧光定量PCR检测巨细胞病毒和EB病毒的自动化核酸提取系统：QIAsymphony RGQ系统与QIAcube系统的比较研究
Ann Lab Med. 2017 Mar;37(2):129-136. doi: 10.3343/alm.2017.37.2.129.
6
Quantitative TaqMan assay for the detection and monitoring of cytomegalovirus infection in organ transplant patients.用于检测和监测器官移植患者巨细胞病毒感染的定量TaqMan检测法。
Methods Mol Biol. 2006;335:147-56. doi: 10.1385/1-59745-069-3:147.
7
Cytomegalovirus DNA quantification using an automated platform for nucleic acid extraction and real-time PCR assay setup.采用自动化核酸提取和实时 PCR 检测平台进行巨细胞病毒 DNA 定量检测。
J Clin Microbiol. 2011 Jul;49(7):2703-5. doi: 10.1128/JCM.00721-11. Epub 2011 May 11.
8
Evaluation of the Automated QIAsymphony SP/AS Workflow for Cytomegalovirus DNA Extraction and Amplification from Dried Blood Spots.用于从干血斑中提取和扩增巨细胞病毒DNA的自动化QIAsymphony SP/AS工作流程的评估
Intervirology. 2016;59(4):211-216. doi: 10.1159/000457953. Epub 2017 Mar 10.
9
Evaluation of a new automated, standardized generic nucleic acid extraction method (total nucleic acid isolation kit) used in combination with cytomegalovirus DNA quantification by COBAS AMPLICOR CMV MONITOR.评估一种新型自动化、标准化通用核酸提取方法（总核酸分离试剂盒）与COBAS AMPLICOR CMV MONITOR进行巨细胞病毒DNA定量分析联合使用的情况。
J Clin Microbiol. 2004 Aug;42(8):3881-2. doi: 10.1128/JCM.42.8.3881-3882.2004.
10
[Nucleic acid-based testing for cytomegalovirus infection].[基于核酸的巨细胞病毒感染检测]
Nihon Rinsho. 2005 Dec;63 Suppl 12:347-52.
引用本文的文献
1
Rapid identification of SARS-CoV-2 in the point-of-care using digital PCR-based Dr. PCR™ Di20K COVID-19 Detection Kit without viral RNA extraction.使用基于数字 PCR 的 Dr. PCR™ Di20K COVID-19 检测试剂盒，无需病毒 RNA 提取，即可在即时检测点快速识别 SARS-CoV-2。
Genes Genomics. 2022 May;44(5):617-628. doi: 10.1007/s13258-022-01242-z. Epub 2022 Mar 30.
2
Evaluation of Three Automated Extraction Systems for the Detection of SARS-CoV-2 from Clinical Respiratory Specimens.用于从临床呼吸道标本中检测新型冠状病毒（SARS-CoV-2）的三种自动提取系统的评估
Life (Basel). 2022 Jan 4;12(1):68. doi: 10.3390/life12010068.
3
Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR.多重引物/探针用于实时 RT-PCR 检测 SARS-CoV-2。
J Clin Virol. 2020 Aug;129:104499. doi: 10.1016/j.jcv.2020.104499. Epub 2020 Jun 8.
4
Validation of SARS-CoV-2 detection across multiple specimen types.多种标本类型中 SARS-CoV-2 检测的验证。
J Clin Virol. 2020 Jul;128:104438. doi: 10.1016/j.jcv.2020.104438. Epub 2020 May 13.
5
Comparison of the new fully automated extraction platform eMAG to the MagNA PURE 96 and the well-established easyMAG for detection of common human respiratory viruses.比较新型全自动提取平台 eMAG 与 MagNA PURE 96 和成熟的 easyMAG 在检测常见人类呼吸道病毒方面的性能。
PLoS One. 2019 Feb 19;14(2):e0211079. doi: 10.1371/journal.pone.0211079. eCollection 2019.
6
Performance Evaluation of the Real-Q Cytomegalovirus (CMV) Quantification Kit Using Two Real-Time PCR Systems for Quantifying CMV DNA in Whole Blood.使用两种实时荧光定量PCR系统对全血中巨细胞病毒（CMV）DNA进行定量的Real-Q巨细胞病毒（CMV）定量试剂盒性能评估
Ann Lab Med. 2016 Nov;36(6):603-6. doi: 10.3343/alm.2016.36.6.603.
本文引用的文献
1
Automated nucleic acid isolation in viral molecular diagnostics: evaluation of the QIAsymphony SP.病毒分子诊断中的自动化核酸提取：QIAsymphony SP评估
Br J Biomed Sci. 2012;69(1):18-25. doi: 10.1080/09674845.2012.11669917.
2
Extraction of viral nucleic acids: comparison of five automated nucleic acid extraction platforms.病毒核酸提取：五种自动化核酸提取平台的比较。
J Clin Virol. 2012 Jul;54(3):255-9. doi: 10.1016/j.jcv.2012.03.008. Epub 2012 Apr 13.
3
Prospective evaluation of a new automated nucleic acid extraction system using routine clinical respiratory specimens.采用常规临床呼吸道标本对新型自动化核酸提取系统的前瞻性评估。
J Med Virol. 2012 Jun;84(6):906-11. doi: 10.1002/jmv.23281.
4
Comparative evaluation of the QIAGEN QIAsymphony® SP system and bioMérieux NucliSens easyMAG automated extraction platforms in a clinical virology laboratory.QIAGEN QIAsymphony SP 系统与 bioMérieux NucliSens easyMAG 自动化提取平台在临床病毒学实验室的比较评估。
J Clin Virol. 2011 Dec;52(4):339-43. doi: 10.1016/j.jcv.2011.08.016. Epub 2011 Oct 20.
5
Problems and challenges in the diagnosis of vertical infection with human cytomegalovirus (CMV): lessons from two accidental cases.人巨细胞病毒（CMV）垂直感染诊断中的问题和挑战：两例意外病例的教训。
J Clin Virol. 2011 Aug;51(4):285-8. doi: 10.1016/j.jcv.2011.05.007.
6
Viral factors influencing the outcome of human cytomegalovirus infection in liver transplant recipients.影响肝移植受者人巨细胞病毒感染结局的病毒因素。
J Clin Virol. 2011 Aug;51(4):229-33. doi: 10.1016/j.jcv.2011.05.012. Epub 2011 Jun 8.
7
Management of cytomegalovirus infection in solid organ transplantation.实体器官移植中巨细胞病毒感染的管理。
Nat Rev Nephrol. 2010 Dec;6(12):711-21. doi: 10.1038/nrneph.2010.141. Epub 2010 Oct 26.
8
Cytomegalovirus infection in pregnancy.妊娠期巨细胞病毒感染
J Obstet Gynaecol Can. 2010 Apr;32(4):348-354. doi: 10.1016/S1701-2163(16)34480-2.
9
Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation.对接受异基因骨髓移植患者的巨细胞病毒疾病采用风险适应性抢先治疗。
Bone Marrow Transplant. 2000 Apr;25(7):765-9. doi: 10.1038/sj.bmt.1702227.
Zotero 插件